Aerie Pharmaceuticals, Inc. Contract Liability (Deferred Revenue)
Aerie Pharmaceuticals, Inc. had Contract Liability (Deferred Revenue) of $85.50 million as of 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2022-11-04
- 2022-09-30: Contract with Customer, Liability, Current $85.50M.
- 2022-06-30: Contract with Customer, Liability, Current $83.28M.
- 2022-03-31: Contract with Customer, Liability, Current $79.21M.
- 2021-12-31: Contract with Customer, Liability, Current $85.38M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2022-09-30 | $85.50M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $83.28M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $79.21M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $85.38M 10-Q · filed 2022-11-04 |
| 2021-09-30 | $79.80M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $73.72M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $61.47M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $66.55M 10-K · filed 2022-02-25 |
| 2020-09-30 | $54.55M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $47.15M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $40.86M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $38.45M 10-K · filed 2021-02-26 |
| 2019-09-30 | $34.06M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $26.05M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $16.50M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $10.15M 10-K · filed 2020-02-24 |
| 2018-09-30 | $4.82M 10-Q · filed 2018-11-07 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |